News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Invitrogen Corporation (IVGN) Release: Life Technologies Corporation (LIFE)'s Solutions Enable Tissue-Engineered Transplant



12/22/2008 8:42:06 AM

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen, part of Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, announced today that GIBCO cell culture media products were used in an experimental procedure to replace the trachea of a woman whose lung had collapsed. The procedure was reported in the November 19, 2008 issue of Lancet, in an article by Macchiarini, et al, entitled “Clinical transplantation of a tissue-engineered airway.”

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES